Mor George Adi 4
4 · Chemomab Therapeutics Ltd. · Filed Jan 5, 2023
Insider Transaction Report
Form 4
Mor George Adi
DirectorChief Executive Officer10% Owner
Transactions
- Sale
American Depositary Shares
2023-01-03$5.03/sh−6,100$30,663→ 251,147 total(indirect: By Spouse) - Award
Option to Purchase American Depositary Shares
2016-10-28+33,725→ 33,725 total(indirect: By Spouse)Exercise: $0.80Exp: 2026-10-27→ American Depositary Shares (33,725 underlying) - Award
Option to Purchase American Depositary Shares
2018-03-15+131,698→ 131,698 totalExercise: $1.49Exp: 2028-03-15→ American Depositary Shares (131,698 underlying) - Sale
American Depositary Shares
2023-01-03$5.03/sh−7,700$38,706→ 317,075 total
Footnotes (5)
- [F1]Each American Depositary Share (ADS) represents twenty (20) ordinary shares, no par value, of the Issuer.
- [F2]This transaction was effected pursuant to a 10b5-1 plan entered into on September 19, 2022.
- [F3]No transaction has been effected by the Reporting Person with respect to these securities, and they are being included in this Form 4 for informational purposes only.
- [F4]These options have vested and are exercisable as of the date hereof.
- [F5]These options have vested and are exercisable as of the date hereof, subject to the Reporting Person's continued service.